LMBCX
Price
$11.42
Change
+$0.06 (+0.53%)
Updated
Dec 20 closing price
VSCPX
Price
$335.64
Change
+$3.61 (+1.09%)
Updated
Dec 20 closing price
Ad is loading...

LMBCX vs VSCPX

Header iconLMBCX vs VSCPX Comparison
Open Charts LMBCX vs VSCPXBanner chart's image
Franklin U.S. Small Cap Equity C
Price$11.42
Change+$0.06 (+0.53%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index InstlPlus
Price$335.64
Change+$3.61 (+1.09%)
VolumeN/A
CapitalizationN/A
LMBCX vs VSCPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LMBCX vs. VSCPX commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMBCX is a Hold and VSCPX is a Buy.

FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 167B vs. LMBCX (104M). VSCPX pays higher dividends than LMBCX: VSCPX (1.44) vs LMBCX (0.00). LMBCX was incepted earlier than VSCPX: LMBCX (16 years) vs VSCPX (14 years). LMBCX is a more actively managed with annual turnover of: 34.00 vs. VSCPX (12.00). LMBCX has a lower initial minimum investment than VSCPX: LMBCX (1000) vs VSCPX (100000000). VSCPX annual gain was more profitable for investors over the last year : 14.57 vs. LMBCX (5.96). VSCPX return over 5 years is better than : 48.10 vs. LMBCX (2.46).
LMBCXVSCPXLMBCX / VSCPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years14 years-
Gain YTD5.66614.07840%
Front LoadN/AN/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets104M167B0%
Annual Yield % from dividends0.001.44-
Returns for 1 year5.9614.5741%
Returns for 3 years-22.4110.66-210%
Returns for 5 years2.4648.105%
Returns for 10 years-10.63116.06-9%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NOTV4.080.24
+6.25%
Inotiv
LVTX1.030.04
+4.16%
LAVA Therapeutics NV
BBD1.930.05
+2.66%
Banco Bradesco SA
SPRY11.18-0.14
-1.24%
ARS Pharmaceuticals
ADMA17.40-0.50
-2.79%
ADMA Biologics